This article was originally published in Start Up
The never-ending search for cancer therapies has led researchers in recent years to consider enzyme-prodrug therapy, a way by which a safe, inactive prodrug is converted into a potent cytotoxic drug at a tumor site by delivery of an activating enzyme. Epttco Ltd. intends to join together several such research efforts.
You may also be interested in...
KuDOS Pharmaceuticals Ltd. aims to discover and develop drugs that inhibit DNA repair. The firm intends to produce compounds that can either enhance chemotherapy or ionizing radiation therapy or have anti-cancer properties in their own right.
Actinova Ltd. is developing antibacterial therapies and vaccines by building on knowledge of bacterial surface proteins inherited from Lund University, Sweden.